Civic Intelligence

David and Janet Polak Foundation

990PF • Fiscal year 2020 • EIN 45-4797578

Jan 01, 2020 to Dec 31, 2020 • Filed on Nov 15, 2021

Organization Profile
Foundation Source 501 Silverside RdWilmington, DE 19809-1377

(800) 839-1754

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

12th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2020 filings • $50M-$100M nonprofits • Source year 2020

Liabilities / Revenue

11th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2020 filings • $50M-$100M nonprofits • Source year 2020

Net Margin

10th percentile

-41%

Higher net margin than 10% of similar nonprofits.

2020 filings • $50M-$100M nonprofits • Source year 2020

Top Officer Pay

44th percentile

$233,800

Higher top officer pay than 44% of similar nonprofits.

Top officer pay equals 7.2% of source-year revenue.

2020 filings • $50M-$100M nonprofits • Source year 2020

Asset Growth

19th percentile

-1.8%

Faster asset growth than 19% of similar nonprofits.

2020 filings • $50M-$100M nonprofits • Annualized from 2019 to 2020

Revenue Growth

18th percentile

-21%

Faster revenue growth than 18% of similar nonprofits.

2020 filings • $50M-$100M nonprofits • Annualized from 2019 to 2020

Balance Sheet
Liabilities / Assets12th percentile

Assets

Down

$71,098,585

Down $1,314,660 (-1.8%) from 2019

Net Assets

$71,098,585

No earlier filing loaded for comparison.

Liabilities

Flat

$0

Flat from 2019

Revenue And Expenses
Liabilities / Revenue11th percentileNet Margin10th percentile

Revenue

Down

$3,236,739

Down $849,992 (-21%) from 2019

Expenses

Up

$4,560,284

Up $700,067 (+18%) from 2019

Net Income

Down

-$1,323,545

Down $1,550,059 (-684%) from 2019

Historical Trend

Balance Sheet Trend

Asset Growth19th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$80M$60M$40M$20M$0Assets 2013: $76,696,942Liabilities 2013: $02013Assets 2014: $74,234,932Liabilities 2014: $02014Assets 2015: $72,956,960Liabilities 2015: $02015Assets 2019: $72,413,245Liabilities 2019: $02019Assets 2020: $71,098,585Liabilities 2020: $0Net Assets 2020: $71,098,5852020Assets 2021: $70,462,786Liabilities 2021: $0Net Assets 2021: $70,462,7862021Assets 2022: $70,845,903Liabilities 2022: $0Net Assets 2022: $70,845,9032022Assets 2023: $70,259,797Liabilities 2023: $0Net Assets 2023: $70,259,7972023Assets 2024: $70,414,478Liabilities 2024: $0Net Assets 2024: $70,414,4782024

Highlighted filing

2020

Assets$71,098,585
Liabilities$0
Net Assets$71,098,585
Open 2020 Filing

Operations Trend

Revenue Growth18th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0M-$4.0MRevenue 2013: $1,756,724Expenses 2013: $1,420,570Net Income 2013: $336,1542013Revenue 2014: $1,805,760Expenses 2014: $4,267,770Net Income 2014: -$2,462,0102014Revenue 2015: $3,395,368Expenses 2015: $4,673,340Net Income 2015: -$1,277,9722015Revenue 2019: $4,086,731Expenses 2019: $3,860,217Net Income 2019: $226,5142019Revenue 2020: $3,236,739Expenses 2020: $4,560,284Net Income 2020: -$1,323,5452020Revenue 2021: $3,446,764Expenses 2021: $4,082,563Net Income 2021: -$635,7992021Revenue 2022: $5,241,349Expenses 2022: $4,859,232Net Income 2022: $382,1172022Revenue 2023: $4,905,865Expenses 2023: $5,496,971Net Income 2023: -$591,1062023Revenue 2024: $4,815,059Expenses 2024: $4,660,378Net Income 2024: $154,6812024

Highlighted filing

2020

Revenue$3,236,739
Expenses$4,560,284
Net Income-$1,323,545
Open 2020 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Nov 15, 2021
Return Version
2020v4.1
Compensation and Service Providers
Top Officer Pay44th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Jeff PolakDir, Pres, Executive DirectorFT$222,800$11,000$233,800
David PolakDirector-$0--
Janet PolakDirector-$0--
Robert PolakDirector-$0--
Jonathan SeltzerDirector-$0--
Filing and Contact Details

Filer

Filer Name
David & Janet Polak Foundation
EIN
45-4797578
In Care Of
% Jeff Polak
Phone
8008391754
Address
Foundation Source 501 Silverside Rd, Wilmington, DE 19809-1377

Signing Officer

Name
Jeff Polak
Title
President
Phone
8008391754
Signed
2021-11-15
Discuss with paid preparer
Yes

Preparer

Firm
Foundation Source
Address
One Hollow Ln Ste 212, Lake Success, NY 11042
Preparer
Jeffrey D Haskell
Phone
8008391754
Raw XML AppendixShowing 400 of 1,602 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
CompensationExplanation/CompensationExplanationGrp/PersonNm0Jeff Polak
CompensationExplanation/CompensationExplanationGrp/ShortExplanationTxt0* david polak (director), Janet polak (director) and jeff POLAK PRESIDENT/DIRECTOR/EXECUTIVE DIRECTOR), OF DAVID & JANET POLAK FOUNDATION (THE "FOUNDATION"), ARE PRINCIPALS AT THE INVESTMENT MANAGEMENT FIRM POLAK INVESTORS, LLC, A DISQUALIFIED PERSON WHICH PROVIDES INVESTMENT MANAGEMENT SERVICES TO THE FOUNDATION. IN THE TAXABLE YEAR ENDING DECEMBER 31, 2020, THE FOUNDATION PAID $374,402 FOR INVESTMENT MANAGEMENT SERVICES RENDERED BY SUCH DISQUALIFIED PERSON, AS REPORTED IN PART I, Line 16c. THE REASONABLENESS OF THE PROFESSIONAL FEES WAS ESTABLISHED BY AN OUTSIDE COMPENSATION COMMITTEE, WHICH REVIEWED THE RATES CHARGED BY COMPARABLE INVESTMENT MANAGEMENT FIRMS.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt0NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt1NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt2NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt3NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt4NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt5NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt6NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt7NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt8NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt9NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt10NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt11NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/AnyDiversionByGranteeTxt12NO
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt0NeuroVision Imaging LLC
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt1Bruin Biometrics LLC
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt2Biop Medical LTD
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt3Online Disruptive Technologies Inc
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt4Orgenesis Ltd
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt5Bryn Pharma LLC fka EPI-Now LLC
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt6CyWat Technologies Ltd
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt7Y&B Mothers Choice Ltd
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt8Y&B Mothers Choice Ltd
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt9MaxQ AI Ltd
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt10ExThera Medical Corporation
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt11YonaLink Ltd
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/BusinessName/BusinessNameLine1Txt12Amicrobe Inc
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt0See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt1See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt2See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt3See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt4See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt5See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt6See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt7See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt8See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt9See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt10See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/DatesOfReportsByGranteeTxt11See General Explanation for Report Dates
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/AddressLine1Txt010 Haeliav St
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/AddressLine1Txt1MATAM Adv Tech Pk bld 23 pobx 15050
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/AddressLine1Txt2Arad Street 9
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/AddressLine1Txt3168 Jabotinsky St
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/AddressLine1Txt4HiTech Vil 4/9 givat ram POB 39231
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/AddressLine1Txt5HiTech Vil 4/9 givat ram POB 39231
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/AddressLine1Txt696 Yigal Alon Street Entrance A
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/AddressLine1Txt7Hadassah Ein Kerem Hosp POB 12000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CityNm0Ramat Gan
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CityNm1haifa
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CityNm2Tel Aviv
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CityNm3Bnei Brak
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CityNm4jerusalem
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CityNm5Jerusalem
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CityNm6Tel Aviv
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CityNm7Jerusalem
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CountryCd0IS
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CountryCd1IS
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CountryCd2IS
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CountryCd3IS
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CountryCd4IS
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CountryCd5IS
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CountryCd6IS
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/CountryCd7IS
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/ForeignPostalCd05252263
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/ForeignPostalCd13190501
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/ForeignPostalCd29129102
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/ForeignPostalCd39129102
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/ForeignPostalCd46789140
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ForeignAddress/ForeignPostalCd59112001
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt0250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt1250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt2250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt3250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt4305498
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt5250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt6250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt7250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt8250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt9250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt10250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt11250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantAmt12250000
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt02014-12-17
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt12015-05-13
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt22017-04-21
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt32017-04-21
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt42017-04-21
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt52018-07-13
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt62018-11-26
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt72018-04-20
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt82018-07-19
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt92019-03-19
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt102019-12-19
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt112019-11-12
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/GrantDt122019-10-31
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt0PRI INVEST-SEE GENERAL EXPLANATION FOR ADDITIONAL INFORMATION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt1PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt2PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt3PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt4PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt5PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt6PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt7PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt8PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt9PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt10PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt11PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/PurposeOfGrantTxt12PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt0The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt1The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt2The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt3The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt4The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt5The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt6The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt7The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt8The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt9The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt10The grantor has no reason to doubt the accuracy or reliability of the report from the grantee; therefore, no independent verification of the report was made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt11The grantor has no reason to doubt the accuracy or reliability of the report from the grantee; therefore, no independent verification of the report was made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/ResultsOfVerificationTxt12The grantor has no reason to doubt the accuracy or reliability of the report from the grantee; therefore, no independent verification of the report was made.
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/AddressLine1Txt01395 Garden Highway Suite 250
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/AddressLine1Txt110960 Wilshire Blvd Suite 950
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/AddressLine1Txt2518 North Hillcrest Road
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/AddressLine1Txt3757 Arnold Drive Suite B
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/AddressLine1Txt43142 Tiger Run Court 103
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/CityNm0Sacramento
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/CityNm1Los Angeles
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/CityNm2Beverly Hills
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/CityNm3Martinez
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/CityNm4Carlsbad
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/StateAbbreviationCd0CA
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/StateAbbreviationCd1CA
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/StateAbbreviationCd2CA
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/StateAbbreviationCd3CA
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/StateAbbreviationCd4CA
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/ZIPCd095833
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/ZIPCd190024
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/ZIPCd290210
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/ZIPCd394553
ExpenditureResponsibilityStmt/ExpenditureResponsibilityGrp/USAddress/ZIPCd492010
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc0FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc1FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc2FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc3FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc4FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc5FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc6FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc7FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc8Forms 8865
GeneralExplanationAttachment/GeneralExplanationGrp/FormAndLineReferenceDesc9PART I LINE 6A (990-PF)
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt0FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt1FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt2FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt3FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt4FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt5FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt6FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt7FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt8Forms 8865
GeneralExplanationAttachment/GeneralExplanationGrp/IdentifierTxt9Part I line 6a
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt0PRI RECIPIENT: NeuroVision Imaging, LLC DATES AND AMOUNTS OF PRI: 12/17/2014 $250,000 5/17/2018 $37,502 PURPOSE OF PRI: Research and development of diagnostic tools for early-stage detection of Alzheimer's disease and other degenerative neurological disorders. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 3/25/2015 FOR FYE 12/31/2014 DATE OF REPORT: 5/18/2016 FOR FYE 12/31/2015 DATE OF REPORT: 6/7/2017 FOR FYE 12/31/2016 DATE OF REPORT: 5/11/2018 FOR FYE 12/31/2017 DATE OF REPORT: 11/1/2019 FOR FYE 12/31/2018 DATE OF REPORT: 6/2/2020 FOR FYE 12/31/2019 DATE OF REPORT: 6/28/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt1PRI RECIPIENT: BRUIN BIOMETRICS, LLC DATE AND AMOUNT OF PRI: 5/13/2015 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY EARLY-STAGE PRESSURE ULCERS DURING THEIR HOSPITAL STAYS AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 5/24/2016 FOR FYE 12/31/2015 DATE OF REPORT: 6/29/2017 FOR FYE 12/31/2016 DATE OF REPORT: 5/15/2018 FOR FYE 12/31/2017 DATE OF REPORT: 6/14/2019 FOR FYE 12/31/2018 DATE OF REPORT: 4/22/2020 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt2PRI RECIPIENT: BIOP MEDICAL LTD DATES AND AMOUNTS OF PRI: 4/21/2017 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY DISEASE AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/4/2018 FOR FYE 12/31/2017 DATE OF REPORT: 2/12/2019 FOR FYE 12/31/2018 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. IN CONNECTION WITH THIS PROGRAM RELATED INVESTMENT ("PRI"), THE FOUNDATION HAS MADE NUMEROUS GOOD FAITH ATTEMPTS TO CONTACT THE INVESTEE AND REQUEST THE OVERDUE ANNUAL REPORTS FROM THE INVESTEE WITH RESPECT TO THE PRI, WHICH ATTEMPTS HAVE BEEN DOCUMENTED BY THE FOUNDATION, BUT HAS NOT BEEN ABLE TO OBTAIN SUCH REPORTS. PER SECTION 53.4945-5(E)(2) OF THE TREASURY REGULATIONS, THE FAILURE OF THE INVESTEE TO SUBMIT SUCH REPORTS WILL NOT RESULT IN A TAXABLE EXPENDITURE FOR THE FOUNDATION BECAUSE THE FOUNDATION (I) MADE THE PRI IN ACCORDANCE WITH PARAGRAPH (B) OF SAID SECTION OF THE REGULATIONS, (II) HAS COMPLIED WITH THE REPORTING REQUIREMENTS CONTAINED IN PARAGRAPH (D) OF SAID SECTION OF THE REGULATIONS, (III) MADE A REASONABLE EFFORT TO OBTAIN THE REQUIRED REPORTS, AND (IV) WILL WITHHOLD ALL FUTURE PRI PAYMENTS TO THE INVESTEE UNTIL SUCH REPORT IS FURNISHED. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt3PRI RECIPIENT: ONLINE DISRUPTIVE TECHNOLOGIES, INC. DATE AND AMOUNT OF PRI: 4/21/2017 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY CANCER AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/6/2018 FOR FYE 12/31/2017 DATE OF REPORT: 2/12/2019 FOR FYE 12/31/2018 DATE OF REPORT: 6/1/2020 FOR FYE 12/31/2019 DATE OF REPORT: 8/18/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt4PRI RECIPIENT: Bryn Pharma LLC f/k/a EPI-Now LLC DATE AND AMOUNT OF PRI: 7/13/2018 $250,000 PURPOSE OF PRI: To promote the health of those who require epinephrine and to advance scientific understanding through research in the public interest. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 8/23/2019 FOR FYE 12/31/2018 DATE OF REPORT: 10/24/2020 FOR FYE 12/31/2019 DATE OF REPORT: 8/2/2021 FOR FYE 12/21/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. appreciation of property.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt5PRI RECIPIENT: Orgenesis Ltd. DATE AND AMOUNT OF PRI: 4/21/2017 $305,498 PURPOSE OF PRI: To promote the health and reduce the suffering of those affected by diabetes by way of researching and bringing to clinical trial the Company technology solution. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 9/9/2018 FOR FYE 12/31/2017 DATE OF REPORT: 10/20/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/20/2020 FOR FYE 12/31/2019 DATE OF REPORT: 5/20/2021 FOR FYE 12/31/2020 THE FOUNDATION EXERCISED AN OPTION TO EXCHANGE ITS INTEREST IN THE INVESTEE FOR THE STOCK IN THE PARENT COMPANY OF THE INVESTED. THIS WAS DONE TO PRESERVE THE PRI AND NOT TO GENERATE INCOME OR FOR THE APPRECIATION OF PROPERTY. THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt6PRI RECIPIENT: CyWat Technologies Ltd DATE AND AMOUNT OF PRI: 11/26/2018 $250,000 PURPOSE OF PRI: To promote the health of people who are affected by polluted drinking water by funding the development of a water monitoring system that is distributed throughout the entire water grid and which can immediately detect potential dangers. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/18/2019 FOR FYE 12/31/2018 DATE OF REPORT: 1/13/2020 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt7PRI RECIPIENT: Y&B MOTHERS CHOICE LTD. DATE AND AMOUNT OF PRI: 4/20/2018 $250,000 PURPOSE OF PRI: TO PROMOTE HEALTH BY FUNDING RESEARCH INTO DEVELOPING NON HAZARDOUS, NATURAL PRODUCTS THAT DO NOT ENDANGER HUMAN HEALTH. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: Y&B MOTHERS CHOICE LTD. DATE AND AMOUNT OF PRI: 7/19/2018 $250,000 PURPOSE OF PRI: TO PROMOTE HEALTH BY FUNDING RESEARCH INTO DEVELOPING NON HAZARDOUS, NATURAL PRODUCTS THAT DO NOT ENDANGER HUMAN HEALTH. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: MAXQ AI, LTD DATE OF PRI: 3/19/2019 $250,000 PURPOSE OF PRI: TO PROMOTE THE DEVELOPMENT OF A PRODUCT THAT WILL SUBSTANTIALLY BENEFIT THE PUBLIC BY INCORPORATING SOPHISTICATED ARTIFICIAL INTELLIGENCE INTO DIAGNOSTIC RADIOLOGY. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/13/2020 FOR FYE 12/31/2019 DATE OF REPORT: 7/20/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: EXTHERA MEDICAL CORPORATION DATE AND AMOUNT OF PRI: 12/19/2019 $250,000 PURPOSE OF PRI: TO FUND THE DEVELOPMENT AND/OR DISTRIBUTION OF CURRENT AND FUTURE MEDICAL TECHNOLOGY, INCLUDING WITHOUT LIMITATION THE SERAPH BLOOD FILTER DEVICE, THAT HAVE A DEMONSTRABLE DEMAND FOR HUMANITARIAN USE IN DEVELOPING COUNTRIES AND THAT OFFER BREAK-THROUGH TECHNOLOGY FOR USE IN THE TREATMENT OF INTRACTABLE OR EMERGING PUBLIC-HEALTH THREATS. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 2/2/2021 FOR FYE 12/31/2019 DATE OF REPORT: 6/30/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: YonaLink Ltd. DATE AND AMOUNT OF PRI: 11/12/2019 $250,000 PURPOSE OF PRI: To finance provision of the YonaLink Automated Study Manager Technology to nonprofit academic hospitals for free or at substantially below cost. The Technology has the potential to significantly improve the quality and efficiency of processing data for clinical research studies in the public interest. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt8The Foundation has prepared these forms to the best of its ability based on the limited information provided to it by the investment on which the Foundation is reporting and on the basis of having received no information to the contrary. Any missing or incomplete information is due to the Foundation's inability to obtain such information and is not a willful attempt to withhold such information.
GeneralExplanationAttachment/GeneralExplanationGrp/MediumExplanationTxt9RECONCILIATION OF NET GAIN/(LOSS) FROM SALES OF ASSETS NOT INCLUDED IN PART IV TOTAL INCLUDED IN PART IV: (DETAILS BELOW) NET GAIN/(LOSS): $1,407,770 TOTAL NOT INCLUDED IN PART IV: PASSTHROUGH K-1 CAPITAL GAIN/(LOSS) - UBI NET GAIN/(LOSS): $240,117 TOTAL PART I, LINE 6A: $1,647,887 DETAILS OF ASSETS INCLUDED IN PART IV: PUBLICLY-TRAIDED SECURITIES GROSS SALES PRICE: $24,661,274 BOOK BASIS: $23,516,717 NET GAIN/(LOSS): $1,144,557 PASSTHROUGH K-1 CAPITAL GAIN/(LOSS) - NON UBI NET GAIN/(LOSS): $222,117 SALES OF OTHER ITEMIZED ASSETS GROSS SALES PRICE: $3,988,374 BOOK BASIS: $3,988,368 NET GAIN/(LOSS): $6 DISTRIBUTIONS IN EXCESS OF BASIS NET GAIN/(LOSS): $41,090
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt0251018
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt1150587
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt2113640
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt3768039
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt4198370
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt5118805
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt6102249
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt732348
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt819784
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt9120095
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt10248049
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt1150603
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt12253526
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt1318674
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt14136767
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt1578225
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt1683405
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt17185100
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt18466000
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt1968217
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt2024396
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt21218701
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt22141284
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt238564
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt2417953
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt2559804
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt26321080
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt27361740
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt28140581
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt2913940
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt3041828
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt31226736
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt32256612
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt33133864
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt3460260
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt35365092
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt3678926
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt37231728
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt38147503
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt3991500
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt40268643
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt4167245
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt4240705
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt43381120
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt44325144
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt4528785
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt46574088
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt4769977
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt489760
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt49103358
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt50490753
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt518916
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt5286644
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt5336513
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt54169858
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt55181332
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt562013
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt5730848
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt5885140
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt59382692
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYBookValueAmt6026941
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt0183480
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt1236320
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt2363720
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt3569500
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt4118720
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt5168570
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt661560
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt732560
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt813400
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt9120060
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt10308300
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt1158240
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt12308600
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt1317480
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt1483940
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt15198800
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt1665650
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt17501000
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt18683000
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt1997600
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt2080420
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt21238860
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt22162425
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt238587
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt2435940
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt2591895
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt26276826
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt27416400
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt28241020
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt2914840
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt3050820
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt31113400
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt32283350
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt33175000
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt34162000
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt35414032
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt36195470
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt37393450
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt38180000
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt3992790
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt40338868
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt41108400
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt4234980
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt43654400
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt44902159
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt45222420
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt46949615
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt47174060
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt489500
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt4978400
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt50736200
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt518279
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt52114800
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt539650
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt5492040
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt55225600
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt561062
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt5747930
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt5862100
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt59175
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/EOYFMVAmt6046494
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm0AMERICAN AXLE & MFG HOLDINGS I
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm1B2 GOLD CORP COM NPV
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm2BANK OF AMERICA CORP
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm3BARRICK GOLD CORPORATION
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm4BAYER A G SPONSORED ADR
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm5BERRY PLASTICS GROUP INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm6BP PLC SPONSORED ADR
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm7CABOT OIL & GAS CORP
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm8CAMECO CORPORATION
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm9CHENIERE ENERGY INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm10CITIGROUP INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm11CLIFFS NATURAL RESOURCES INC.
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm12COMPASS MINERALS INTERNATIONAL
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm13COMSTOCK RES INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm14CONSTELLIUM NV
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm15COPPER MOUNTAIN MINI NG CORP
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm16COVANTA HOLDING CORP
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm17CROWN HOLDINGS INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm18CVS CAREMARK CORP
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm19DANA HOLDING CP
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm20DELTA AIR LINES INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm21ELDORADO GOLD CORP COM NPV
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm22ENDEAVOUR MINING CORP
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm23FIDELITY CONSERV INC BD FD
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm24FIRST QUANTUM MINERALS LTD
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm25FLUTTER ENTERTAINMENT ORD SHS
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm26FTS INTERNATIONAL INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm27GENERAL MOTORS
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm28GOLD FIELDS LTD ADS
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm29GOLDEN STAR RESOURCES LTD
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm30GRAPHIC PACKAGING CORP COM STK
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm31HALLIBURTON COMPANY
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm32HOLCIM N
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm33HUDBAY MINERALS INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm34IVANHOE MINES LTD
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm35JAPAN SMALLER CAPITALIZATION F
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm36JET2 PLC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm37JOHNSON & JOHNSON
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm38KAZATOMPROM JSC NAC GDR
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm39KBR INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm40KIRKLAND LAKE GOLD LTD
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm41LAFARGEHOLCIM LTD ADR
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm42MARKET VECTORS VIETNAM ETF
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm43MERCK & CO INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm44MICRON TECHNOLOGY
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm45MICROSOFT CORP
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm46NEWMONT GOLDCORP CORPORATION
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm47NOVAGOLD RESOURCES
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm48NUVEEN MLT STR I&G
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm49OCEANAGOLD CORPORATION COM
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm50PFIZER INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm51PHILIP MORRIS INTL
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm52PRETIUM RESOURCES INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm53TEVA PHARMACEUTICAL INDUSTRIES
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm54THE MOSAIC CO
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm55TOREX GOLD RESOURCES
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm56TPG RE FINANCE TRUST INC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm57TRUIST FINANCIAL CORPORATION
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm58TURQUOISE HILL RESOURCES LTD
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm59VALARIS PLC
InvestmentsCorpStockSchedule/InvestmentsCorporateStockGrp/StockNm60VIATRIS ORD SHS
InvestmentsGovtObligationsSch/StateLocalSecBookVlEOYAmt03545065
InvestmentsGovtObligationsSch/StateLocalSecEOYFMVAmt03724010
InvestmentsGovtObligationsSch/USGovtObligationsBookVlEOYAmt030238616
InvestmentsGovtObligationsSch/USGovtObligationsEOYFMVAmt030426972
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt02020814
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt12033480
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt2496156
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt3212783
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt4659098
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt5182992
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt6897667
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt71000000
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt8424573
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt9188581
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt10984325
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt11556167
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt12834921
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt13251807
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt14302066
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt15402725
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt16133187
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt176463
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt1879926
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt19287336
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt20272291
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt2159065
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt221434
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt2366759
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt24500000
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt251500000
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt262533796
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt27556154
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt28263639
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt291670998
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt301249841
InvestmentsOtherSchedule2/InvestmentsOtherGrp/BookValueAmt31530622
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt0AIR U.S. LIFE FUND III, LP
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt1AIR US LIFE FUND IV, LP
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt2ALTAIR - PACIFIC COAST CPTL PT
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt3ALTAIR DIRECT LENDING FUND, LL
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt4ALTAIR EUROPEAN R E OPPORTUNIT
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt5ALTAIR SENIOR HOUSING FUND (AE
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt6ANAGENESIS CAPITAL PARTNERS SB
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt7ASM CONNAUGHT HOUSE FUND III L
InvestmentsOtherSchedule2/InvestmentsOtherGrp/CategoryOrItemTxt8BROAD ST REAL ESTATE CREDIT PT

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2020 • Form 990PFDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$71,098,585
Liabilities
$0
Net assets
$71,098,585
Revenue
$3,236,739
Expenses
$4,560,284
Net income
-$1,323,545
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$70.4$0.00$70.4$4.82$4.66$0.15
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$70.3$0.00$70.3$4.91$5.50$0.59
2022Detailed filing. Detailed filing data is available for this year.$70.8$0.00$70.8$5.24$4.86$0.38
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$70.5$0.00$70.5$3.45$4.08$0.64
2020Detailed filing. Detailed filing data is available for this year.$71.1$0.00$71.1$3.24$4.56$1.32
2019Summary only. Only limited summary data is available for this year.$72.4$0.00$4.09$3.86$0.23
2015Summary only. Only limited summary data is available for this year.$73.0$0.00$3.40$4.67$1.28
2014Summary only. Only limited summary data is available for this year.$74.2$0.00$1.81$4.27$2.46
2013Summary only. Only limited summary data is available for this year.$76.7$0.00$1.76$1.42$0.34